About this trial
The goal of this observational longitudinal study is to investigate characteristics and factors associated with the development of Severe and Enduring Eating Disorders (SEED). In this project, the researchers will follow two prospective cohorts of patients with eating disorders (ED), one adolescent (ages 14-17) and one adult (ages 18+), in terms of change in and impact of clinical, psychological, and biological risk factors.
Data will be collected at baseline, after treatment, two years after baseline, and thereafter five, 10 and 20 years after baseline. Participants will be asked to undergo a physical examination, leave blood samples, be interviewed, and fill in questionnaires. If the participants are minors, their care takers will also fill in the questionnaires.
The study aims to explore how clinical, psychological, and biological risk factors-including comorbidity, personality characteristics, difficulties with emotion regulation (ER), cognitive inflexibility, loneliness, severe ED symptoms, and inflammatory activation-contribute to a chronic course of the disorder.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
found to meet the criteria for an eating disorder
being in need of treatment
having provided written informed consent (for minors, this includes consent from all caregivers and the minors themselves).
Disqualifiers
Eating disorders symptoms in need of emergency care
High risk for suicide
An inability to respond to the questionnaires due to e.g., lack of knowledge in Swedish.
Trial population
Two prospective cohorts of patients with ED, one adolescent and one adult, will be followed in terms of change in and impact of clinical factors, personality style, ER difficulties, loneliness, and biomarkers from baseline, after treatment, two years after baseline, and after five, 10 and 20 years. These cohorts will be consecutively recruited from 2024 onwards from the Eating Disorder Unit at the Uppsala Department of Child and Adolescent Psychiatry (CAP), from 14 to17 years of age, and the Uppsala Department of Psychiatry (P), from 18 years of age.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Eating disorder examination interview (EDE-I)
EDE-I is a semi-structured interview for assessing symptoms of and diagnosing eating disorders, including providing information for grading severity according to e.g., the DSM 5. The EDE-I assesses a variety of eating disorder behaviors, weight control behaviors, and behavioral and cognitive features of eating disorder psychopathology.
Eating disorder Examination Questionnaire (EDE-Q)
EDE-Q is a 28-item self-report questionnaire, designed to assess the range, frequency and severity of behaviors associated with an eating disorder. It is categorized into four sub-scales: Restraint, Eating Concern, Shape Concern and Weight Concern, and an overall global score. The score is obtained by calculating the mean for the total score and the subscales respectively (min = 0, max =6), higher scores indicate more severe eating disorder symptoms.
Eating Disorder-15 (ED-15) and for parents/caregivers (ED-15-P)
ED-15 assesses eating disorder attitudes and behaviors on a 15-item Likert scale, which includes 10 attitudinal items (scored from 0-6) and 5 items for frequency grading. ED-15-P include the same items but is answered by the youths caregiver instead. The ED-15 includes two attitudinal subscales: Weight \& shape concerns and Eating concerns. The Overall attitudinal score is the mean of the scores on all ten items. Higher scores indicate more severe eating disorder symptoms.
Clinical Global Impression-Severity (CGI-S)
Global clinical rating of symptom severity on an 8-grade Likert scale (scored between 0-7). The CGI offers a clinician-determined summary that incorporates all available information, including the patient's history, psychosocial context, symptoms, behavior, and the impact of these symptoms on their functional ability. A higher score indicates a more severe psychopathology.
Secondary outcomes
Clinical Impairment Assessment questionnaire (CIA)
The CIA is a 16-item self-report measure of the severity of psychosocial impairment due to eating disorder features, Each item is rated on a four-point Likert scale ranging from 'Not at all' to 'A lot'. The minimun score is zero and the maximum score is 48, with higher scores indicating a more severe impairment.
WHO Disability Assessment Schedule (WHODAS 2.0)
WHODAS 2.0 measure individual dysfunction in six domains of daily activities (cognition, mobility, self-care, relationships with people, life activities, and participation). It is measured on a five-point Likert scale ranging from no difficulty, to extreme difficulty. The score is calculated by dividing the total score with the number of items, resulting in a minimum score of zero and maximum score of 4. Higher scores indicate higher disability.
Uppsala scale of Functional Impairment in Daily life (UFID and UFID-P for parents)
The UFID is a Five-item, five-point Likert scale that measures functional impairment in daily life on a score between 1-5. UFID-P includes the same items but is answered by the caregiver instead. Higher scores indicate more functional impairment.
Children's Global Assessment Scale (CGAS)
CGAS is a rating of general functioning for children and young people aged 4-16 years old. The clinician assesses a range of aspects of psychological and social functioning and gives the child or young person a single score between 1 and 100, based on their lowest level of functioning.
Other outcomes
The Avoidance and Fusion Questionnaire for Youth (AFQ-Y)
The AFQ-Y is a self-rating instrument that measures psychological inflexibility. Participants rate their level of agreement on eight items on a 5-point Likert measuring one single factor. Score range is 0-24 and higher scores indicate a higher level of psychological inflexibility.
Emotion Regulation Questionnaire (ERQ)
The ERQ is a self-rating instrument designed to assess individual differences in the use of emotion regulation strategies. It is composed of ten items divided into two factors: cognitive reappraisal and expressive suppression. Participants indicate their answers on a 7-point Likert-scale ranging from 1 (total disagreement) to 7 (total agreement).
Swedish universities Scale of Personality (SSP)
SSP is a self-report instrument assessing personality traits corresponding to biological correlates. It contains 91 items divided into 13 subscales. The scale can also be divided into a three-factor solution with Factor 1 reflecting Neuroticism; Factor 2 reflecting Aggressiveness; and Factor 3 reflecting Extraversion. Each item is given as a statement with a four-point response format, ranging from does not apply at all to applies completely. It is presented in standardized t-score ranging from 0-100 (mean 50 and standard deviation 10). Higher scorer indicate more pronounced characteristics of that specific trait.
Neuroticism-Extraversion-Openness Personality Inventory (NEO-PI)
The NEO-PI is a self-report instrument designed to assess personality traits based on the Five-Factor Model of personality. It consists of 240 items grouped into five main domains: Neuroticism, Extraversion, Openness to Experience, Agreeableness, and Conscientiousness. Each domain is further divided into six specific facets, providing a detailed profile of personality traits. Responses are rated on a five-point Likert scale, ranging from "Strongly Disagree" to "Strongly Agree." Scores are typically presented as standardized T-scores, with higher scores indicating a stronger expression of the respective traits.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Uppsala University Hospital
Lead sponsor
Forte
Collaborator
The Söderström König Foundation
Collaborator
Fonden för psykisk hälsa
Collaborator